Co-Authors
This is a "connection" page, showing publications co-authored by CAROLINE CHUNG and DEBRA NANA YEBOA.
Connection Strength
1.561
-
Additive Value of Magnetic Resonance Simulation Before Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas. Pract Radiat Oncol. 2024 Nov-Dec; 14(6):e449-e457.
Score: 0.240
-
Hypofractionated radiotherapy for glioblastoma: A large institutional retrospective assessment of 2 approaches. Neurooncol Pract. 2024 Jun; 11(3):266-274.
Score: 0.236
-
The Effect of Slice Thickness on Contours of Brain Metastases for Stereotactic Radiosurgery. Adv Radiat Oncol. 2021 Jul-Aug; 6(4):100708.
Score: 0.194
-
Association Between Facility Volume and Overall Survival for Patients with Grade II Meningioma after Gross Total Resection. World Neurosurg. 2020 09; 141:e133-e144.
Score: 0.183
-
National Patterns of Care in the Management of World Health Organization Grade II and III Spinal Ependymomas. World Neurosurg. 2019 Apr; 124:e580-e594.
Score: 0.166
-
The Use of 68Ga-DOTATATE PET/CT in the Non-invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report. Front Oncol. 2018; 8:454.
Score: 0.164
-
Outcomes and Pattern of Care for Spinal Myxopapillary Ependymoma in the Modern Era-A Population-Based Observational Study. Cancers (Basel). 2024 May 25; 16(11).
Score: 0.060
-
Response of treatment-naive brain metastases to stereotactic radiosurgery. Nat Commun. 2024 May 02; 15(1):3728.
Score: 0.060
-
Changes in outcomes and factors associated with survival in melanoma patients with brain metastases. Neuro Oncol. 2023 Jul 06; 25(7):1310-1320.
Score: 0.057
-
Nivolumab and ipilimumab with concurrent stereotactic radiosurgery for intracranial metastases from non-small cell lung cancer: analysis of the safety cohort for non-randomized, open-label, phase I/II trial. J Immunother Cancer. 2023 07; 11(7).
Score: 0.057
-
A Prospective Study of Conventionally Fractionated Dose Constraints for Reirradiation of Primary Brain Tumors in Adults. Pract Radiat Oncol. 2023 May-Jun; 13(3):231-238.
Score: 0.055
-
Radiation for Glioblastoma in the Era of Coronavirus Disease 2019 (COVID-19): Patient Selection and Hypofractionation to Maximize Benefit and Minimize Risk. Adv Radiat Oncol. 2020 Jul-Aug; 5(4):743-745.
Score: 0.046
-
Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol. 2019 08; 16(8):521-522.
Score: 0.043